Bioconjugate Chemistry · 1995 · 65 citations · 16 references
PharmacyPharmaceuticsPharmacokineticsBioavailabilityDrug DeliveryTargeted Drug DeliveryDrug EncapsulationLipid-based Drug Delivery SystemsLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsPeptide DeliveryLiposomal Delivery SystemsLiposomal NanocarriersLiposome Drug DeliveryLiposome Surface ModificationLiposomesLong-circulating LiposomesSystemic DeliverySystemic Drug Delivery
Poly(ethylene glycol) (PEG)-grafted liposomes offer new opportunities as long-circulating platforms presenting biologically relevant ligands. In pursuit of this goal, liposomal conjugates of YIGSR were prepared by mild periodate oxidation of TYIGSR-NH2 and incubation of the product with hydrazide-PEG-(distearoylphosphatidyl)ethanolamine-containing liposomes. The peptide-carrying liposomes, with up to 500 YIGSR residues per vesicle, despite exhibiting faster blood clearance rates than the parent liposomes in rats, remained in circulation for extended periods of time. Mean residence times for the parent liposomal formulation and conjugated preparations containing 200 and 500 YIGSR residues per vesicle were 28, 25, and 23 h, respectively. The results have important implications for systemic delivery of peptides and for their use as targeting moieties for PEG-grafted liposomes.
16
YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation
Yukihide Iwamoto, Frank A. Robey, Jeannette Graf et al. · Science · 1987 · 556 citations
Medicine, Cancer Biology, Oncology +13
A.L. Klibanov, Kazuo Maruyama, Anne Marie Beckerleg et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1991 · 483 citations
Kieran F. Geoghegan, Justin G. Stroh · Bioconjugate Chemistry · 1992 · 353 citations